

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 6.59206227 |
| 2 | vocalization behavior (GO:0071625) | 6.38035476 |
| 3 | positive regulation of catecholamine secretion (GO:0033605) | 5.57545386 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.08480907 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.07705481 |
| 6 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.97016342 |
| 7 | protein localization to synapse (GO:0035418) | 4.85877013 |
| 8 | serotonin receptor signaling pathway (GO:0007210) | 4.82885841 |
| 9 | presynaptic membrane assembly (GO:0097105) | 4.73121286 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.56420287 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52237533 |
| 12 | postsynaptic membrane organization (GO:0001941) | 4.50359960 |
| 13 | ganglion development (GO:0061548) | 4.49163304 |
| 14 | alkaloid metabolic process (GO:0009820) | 4.38166637 |
| 15 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.34691320 |
| 16 | cerebellar Purkinje cell layer development (GO:0021680) | 4.33290970 |
| 17 | neuron recognition (GO:0008038) | 4.29969472 |
| 18 | glutamate secretion (GO:0014047) | 4.29069110 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.26673615 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.25808690 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.25292028 |
| 22 | startle response (GO:0001964) | 4.21115074 |
| 23 | nucleobase catabolic process (GO:0046113) | 4.19839057 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.16530739 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 4.16022370 |
| 26 | presynaptic membrane organization (GO:0097090) | 4.15831208 |
| 27 | heart field specification (GO:0003128) | 4.14768438 |
| 28 | secondary heart field specification (GO:0003139) | 4.14768438 |
| 29 | regulation of catecholamine secretion (GO:0050433) | 4.11295814 |
| 30 | retinal ganglion cell axon guidance (GO:0031290) | 4.09293798 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.08738803 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 4.08416452 |
| 33 | negative regulation of norepinephrine secretion (GO:0010700) | 4.08169879 |
| 34 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.07603006 |
| 35 | transmission of nerve impulse (GO:0019226) | 4.04532321 |
| 36 | negative regulation of microtubule polymerization (GO:0031115) | 4.02638500 |
| 37 | response to histamine (GO:0034776) | 3.94121341 |
| 38 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.93220461 |
| 39 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.92962490 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.92595191 |
| 41 | drinking behavior (GO:0042756) | 3.91197114 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.87081748 |
| 43 | regulation of axon guidance (GO:1902667) | 3.85116770 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.83946262 |
| 45 | synaptic transmission, glutamatergic (GO:0035249) | 3.81992799 |
| 46 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.81624149 |
| 47 | positive regulation of synapse assembly (GO:0051965) | 3.80669697 |
| 48 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.79870922 |
| 49 | gamma-aminobutyric acid transport (GO:0015812) | 3.77831298 |
| 50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.76084600 |
| 51 | regulation of synaptic vesicle transport (GO:1902803) | 3.75549814 |
| 52 | germ cell migration (GO:0008354) | 3.74053382 |
| 53 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.68837752 |
| 54 | layer formation in cerebral cortex (GO:0021819) | 3.68354410 |
| 55 | dopamine biosynthetic process (GO:0042416) | 3.67226453 |
| 56 | striatum development (GO:0021756) | 3.66034976 |
| 57 | regulation of timing of cell differentiation (GO:0048505) | 3.64398978 |
| 58 | regulation of dopamine metabolic process (GO:0042053) | 3.64080637 |
| 59 | regulation of catecholamine metabolic process (GO:0042069) | 3.64080637 |
| 60 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.60295342 |
| 61 | regulation of development, heterochronic (GO:0040034) | 3.59133590 |
| 62 | central nervous system neuron axonogenesis (GO:0021955) | 3.58383140 |
| 63 | synapse assembly (GO:0007416) | 3.55223642 |
| 64 | neurotransmitter transport (GO:0006836) | 3.54678910 |
| 65 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.54103405 |
| 66 | axonal fasciculation (GO:0007413) | 3.53472057 |
| 67 | dendrite development (GO:0016358) | 3.51206409 |
| 68 | exploration behavior (GO:0035640) | 3.50735370 |
| 69 | positive regulation of dendritic spine development (GO:0060999) | 3.49736183 |
| 70 | locomotory exploration behavior (GO:0035641) | 3.49613635 |
| 71 | cardiac left ventricle morphogenesis (GO:0003214) | 3.46608323 |
| 72 | proline transport (GO:0015824) | 3.46590373 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 3.46236991 |
| 74 | regulation of synapse structural plasticity (GO:0051823) | 3.45890813 |
| 75 | synaptic vesicle maturation (GO:0016188) | 3.45377136 |
| 76 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.42439630 |
| 77 | protein-cofactor linkage (GO:0018065) | 3.41850455 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.40851068 |
| 79 | somite development (GO:0061053) | 3.40811353 |
| 80 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.39593623 |
| 81 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.39593623 |
| 82 | positive regulation of calcium ion import (GO:0090280) | 3.39579032 |
| 83 | social behavior (GO:0035176) | 3.39119193 |
| 84 | intraspecies interaction between organisms (GO:0051703) | 3.39119193 |
| 85 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.36133684 |
| 86 | transferrin transport (GO:0033572) | 3.35905610 |
| 87 | positive regulation of action potential (GO:0045760) | 3.34481619 |
| 88 | cell migration in hindbrain (GO:0021535) | 3.33810244 |
| 89 | regulation of dopamine secretion (GO:0014059) | 3.33702843 |
| 90 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.33448429 |
| 91 | regulation of synapse assembly (GO:0051963) | 3.33216829 |
| 92 | response to mineralocorticoid (GO:0051385) | 3.32764111 |
| 93 | adult walking behavior (GO:0007628) | 3.31700693 |
| 94 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.30726424 |
| 95 | neurofilament cytoskeleton organization (GO:0060052) | 3.30108191 |
| 96 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.29939340 |
| 97 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.29931390 |
| 98 | behavioral response to nicotine (GO:0035095) | 3.29237580 |
| 99 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.27406669 |
| 100 | regulation of postsynaptic membrane potential (GO:0060078) | 3.25189082 |
| 101 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.22834356 |
| 102 | sympathetic nervous system development (GO:0048485) | 3.22374855 |
| 103 | G-protein coupled receptor internalization (GO:0002031) | 3.20208315 |
| 104 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.20141612 |
| 105 | fear response (GO:0042596) | 3.17585112 |
| 106 | righting reflex (GO:0060013) | 3.17483579 |
| 107 | behavioral defense response (GO:0002209) | 3.16427091 |
| 108 | behavioral fear response (GO:0001662) | 3.16427091 |
| 109 | protein polyglutamylation (GO:0018095) | 3.16418754 |
| 110 | RNA destabilization (GO:0050779) | 3.14904100 |
| 111 | regulation of vesicle fusion (GO:0031338) | 3.14754306 |
| 112 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.14171330 |
| 113 | parturition (GO:0007567) | 3.13457326 |
| 114 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.12720512 |
| 115 | trivalent inorganic cation transport (GO:0072512) | 3.12674348 |
| 116 | ferric iron transport (GO:0015682) | 3.12674348 |
| 117 | auditory behavior (GO:0031223) | 3.12440872 |
| 118 | synaptic transmission, cholinergic (GO:0007271) | 3.12140133 |
| 119 | negative regulation of cAMP biosynthetic process (GO:0030818) | 3.11139807 |
| 120 | spinal cord motor neuron differentiation (GO:0021522) | 3.11122933 |
| 121 | neuromuscular synaptic transmission (GO:0007274) | 3.09130464 |
| 122 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.09051481 |
| 123 | vesicle transport along microtubule (GO:0047496) | 3.09039693 |
| 124 | establishment of mitochondrion localization (GO:0051654) | 3.07594442 |
| 125 | response to insecticide (GO:0017085) | 3.07552657 |
| 126 | mechanosensory behavior (GO:0007638) | 3.06929987 |
| 127 | long-term synaptic potentiation (GO:0060291) | 3.06831183 |
| 128 | negative regulation of dendrite development (GO:2000171) | 3.06707668 |
| 129 | chaperone-mediated protein transport (GO:0072321) | 3.05222368 |
| 130 | positive regulation of amine transport (GO:0051954) | 3.04964966 |
| 131 | membrane depolarization (GO:0051899) | 3.04906798 |
| 132 | regulation of neuron migration (GO:2001222) | 3.01161990 |
| 133 | membrane hyperpolarization (GO:0060081) | 3.01075261 |
| 134 | regulation of glutamate secretion (GO:0014048) | 3.01041280 |
| 135 | membrane depolarization during action potential (GO:0086010) | 3.00715240 |
| 136 | negative regulation of catecholamine secretion (GO:0033604) | 3.00320970 |
| 137 | forebrain neuron development (GO:0021884) | 3.00100883 |
| 138 | synapse organization (GO:0050808) | 2.99270805 |
| 139 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.99266472 |
| 140 | regulation of respiratory system process (GO:0044065) | 2.98945682 |
| 141 | DNA damage response, detection of DNA damage (GO:0042769) | 2.98411524 |
| 142 | catecholamine transport (GO:0051937) | 2.98179068 |
| 143 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.98073565 |
| 144 | regulation of respiratory gaseous exchange (GO:0043576) | 2.97978321 |
| 145 | * synaptic transmission (GO:0007268) | 2.97085308 |
| 146 | regulation of synapse organization (GO:0050807) | 2.96148252 |
| 147 | negative regulation of cAMP metabolic process (GO:0030815) | 2.95789970 |
| 148 | oxidative demethylation (GO:0070989) | 2.94385470 |
| 149 | specification of organ identity (GO:0010092) | 2.93986567 |
| 150 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.93331947 |
| 151 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.93331947 |
| 152 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.93331947 |
| 153 | response to cocaine (GO:0042220) | 2.92040222 |
| 154 | synaptic transmission, dopaminergic (GO:0001963) | 2.91012979 |
| 155 | regulation of feeding behavior (GO:0060259) | 2.90728353 |
| 156 | glucocorticoid biosynthetic process (GO:0006704) | 2.89379678 |
| 157 | DNA double-strand break processing (GO:0000729) | 2.88894796 |
| 158 | dendritic spine morphogenesis (GO:0060997) | 2.88286859 |
| 159 | positive regulation of protein homodimerization activity (GO:0090073) | 2.87461899 |
| 160 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 2.85372917 |
| 161 | hypothalamus development (GO:0021854) | 2.84730005 |
| 162 | ubiquinone metabolic process (GO:0006743) | 2.83058621 |
| 163 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.82496152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.46836060 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.99531944 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.55827517 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.47610165 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.13945405 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96381673 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82076315 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76805484 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.65353281 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.57233230 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54610397 |
| 12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.52369329 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47456321 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47456321 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45479061 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.42484180 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.37394791 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.37284676 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.34708871 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32317941 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.31761285 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27315278 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25915902 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25149164 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.24070227 |
| 26 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20212371 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12205292 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12176453 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11679951 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06472711 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99630204 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97170227 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.92543285 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91899345 |
| 35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91836462 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.90314378 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87605800 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86608220 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77188562 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74706604 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71400230 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68378638 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67931088 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66864055 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.63569779 |
| 46 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60750658 |
| 47 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.59176763 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.59089835 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56355090 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.55032228 |
| 51 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54273303 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42773277 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41995104 |
| 54 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.40942579 |
| 55 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40232699 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38770658 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36739614 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36456366 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35914623 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34637241 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34637241 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34037891 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25469770 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24966289 |
| 65 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24021214 |
| 66 | JUN_21703547_ChIP-Seq_K562_Human | 1.22730843 |
| 67 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22521743 |
| 68 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21860067 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19009294 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17608668 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17418307 |
| 72 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17073481 |
| 73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15445621 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13624005 |
| 75 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13306473 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13265285 |
| 77 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12882234 |
| 78 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.11333980 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.10696263 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10468065 |
| 81 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.07386667 |
| 82 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04925806 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04055724 |
| 84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.03250883 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03250880 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02818135 |
| 87 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02594474 |
| 88 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99911410 |
| 89 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99911410 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99817244 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99323098 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99206644 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97746307 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97557901 |
| 95 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97281220 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96135427 |
| 97 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96085903 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94440059 |
| 99 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92452162 |
| 100 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91608339 |
| 101 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91195462 |
| 102 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90944160 |
| 103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.90691045 |
| 104 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90654589 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89319187 |
| 106 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88848787 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87880941 |
| 108 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87328473 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86591671 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85852008 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85757327 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.85662798 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85627919 |
| 114 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85227998 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.85186477 |
| 116 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.83073530 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82900265 |
| 118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82583008 |
| 119 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82332298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.46253213 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.26229983 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.62442652 |
| 4 | MP0009745_abnormal_behavioral_response | 3.48816975 |
| 5 | MP0006276_abnormal_autonomic_nervous | 3.44386707 |
| 6 | MP0002064_seizures | 3.21814428 |
| 7 | MP0001440_abnormal_grooming_behavior | 3.13973778 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.11182586 |
| 9 | MP0009046_muscle_twitch | 3.01744541 |
| 10 | MP0004270_analgesia | 2.91651259 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.82888582 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.81218876 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.68523071 |
| 14 | MP0001486_abnormal_startle_reflex | 2.65647815 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.58592544 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.54947751 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 2.47546228 |
| 18 | MP0000516_abnormal_urinary_system | 2.47546228 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.44135449 |
| 20 | MP0002272_abnormal_nervous_system | 2.41797701 |
| 21 | MP0003122_maternal_imprinting | 2.37297088 |
| 22 | MP0001529_abnormal_vocalization | 2.32893061 |
| 23 | * MP0001501_abnormal_sleep_pattern | 2.32843295 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.26409188 |
| 25 | MP0002736_abnormal_nociception_after | 2.14345829 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.12336100 |
| 27 | MP0001970_abnormal_pain_threshold | 2.11438276 |
| 28 | MP0002184_abnormal_innervation | 1.97322327 |
| 29 | MP0001905_abnormal_dopamine_level | 1.95669089 |
| 30 | MP0002822_catalepsy | 1.94658688 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.93367829 |
| 32 | MP0003890_abnormal_embryonic-extraembry | 1.90036710 |
| 33 | MP0001188_hyperpigmentation | 1.86663037 |
| 34 | MP0000778_abnormal_nervous_system | 1.75520124 |
| 35 | MP0004142_abnormal_muscle_tone | 1.75134256 |
| 36 | MP0003787_abnormal_imprinting | 1.71458472 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.70464568 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.65851792 |
| 39 | MP0004924_abnormal_behavior | 1.62292675 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.62292675 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.60511910 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.54885590 |
| 43 | MP0008995_early_reproductive_senescence | 1.53944810 |
| 44 | MP0005187_abnormal_penis_morphology | 1.53329096 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.52051101 |
| 46 | MP0003329_amyloid_beta_deposits | 1.51050735 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.49441334 |
| 48 | MP0009278_abnormal_bone_marrow | 1.44097214 |
| 49 | MP0000955_abnormal_spinal_cord | 1.41784959 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.38624701 |
| 51 | MP0003121_genomic_imprinting | 1.34278276 |
| 52 | MP0003879_abnormal_hair_cell | 1.30368515 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.28608311 |
| 54 | MP0005647_abnormal_sex_gland | 1.26626912 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.26545741 |
| 56 | MP0008569_lethality_at_weaning | 1.25852460 |
| 57 | MP0003718_maternal_effect | 1.25447886 |
| 58 | MP0002163_abnormal_gland_morphology | 1.24418732 |
| 59 | MP0000751_myopathy | 1.23677397 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.23213202 |
| 61 | MP0003011_delayed_dark_adaptation | 1.22584555 |
| 62 | MP0002638_abnormal_pupillary_reflex | 1.21000601 |
| 63 | MP0003123_paternal_imprinting | 1.20692788 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.19926176 |
| 65 | MP0002102_abnormal_ear_morphology | 1.19190105 |
| 66 | MP0001984_abnormal_olfaction | 1.18773195 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.14354645 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.13535158 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.10503095 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.09434040 |
| 71 | MP0001664_abnormal_digestion | 1.08613714 |
| 72 | MP0004742_abnormal_vestibular_system | 1.08475882 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.06909077 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.01449335 |
| 75 | MP0002152_abnormal_brain_morphology | 0.99822251 |
| 76 | MP0003690_abnormal_glial_cell | 0.99295288 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.97025068 |
| 78 | MP0002234_abnormal_pharynx_morphology | 0.94999627 |
| 79 | MP0008872_abnormal_physiological_respon | 0.94941788 |
| 80 | MP0005503_abnormal_tendon_morphology | 0.94553621 |
| 81 | MP0004085_abnormal_heartbeat | 0.92558561 |
| 82 | MP0004858_abnormal_nervous_system | 0.91558838 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.91429479 |
| 84 | MP0005535_abnormal_body_temperature | 0.91037823 |
| 85 | MP0001919_abnormal_reproductive_system | 0.89926031 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.89141310 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.88824497 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.88064929 |
| 89 | MP0004133_heterotaxia | 0.87800392 |
| 90 | MP0008874_decreased_physiological_sensi | 0.85847051 |
| 91 | MP0001177_atelectasis | 0.85791897 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.85353821 |
| 93 | MP0002282_abnormal_trachea_morphology | 0.85268483 |
| 94 | MP0004147_increased_porphyrin_level | 0.83537690 |
| 95 | MP0005253_abnormal_eye_physiology | 0.82168082 |
| 96 | MP0002160_abnormal_reproductive_system | 0.81280897 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.80792342 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 0.80606131 |
| 99 | MP0002229_neurodegeneration | 0.79895427 |
| 100 | MP0003861_abnormal_nervous_system | 0.79764781 |
| 101 | MP0005389_reproductive_system_phenotype | 0.79447029 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.79314796 |
| 103 | MP0000538_abnormal_urinary_bladder | 0.79091856 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.78059297 |
| 105 | MP0003119_abnormal_digestive_system | 0.74328882 |
| 106 | MP0000462_abnormal_digestive_system | 0.74104879 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.74043648 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.73510178 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.73510178 |
| 110 | MP0004233_abnormal_muscle_weight | 0.73466028 |
| 111 | MP0002752_abnormal_somatic_nervous | 0.73166773 |
| 112 | MP0008770_decreased_survivor_rate | 0.73163010 |
| 113 | MP0003633_abnormal_nervous_system | 0.73015276 |
| 114 | MP0003631_nervous_system_phenotype | 0.72285532 |
| 115 | MP0004885_abnormal_endolymph | 0.69242904 |
| 116 | MP0002127_abnormal_cardiovascular_syste | 0.68794247 |
| 117 | MP0003567_abnormal_fetal_cardiomyocyte | 0.67379504 |
| 118 | MP0000604_amyloidosis | 0.66729825 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.66532324 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.66229756 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.63037943 |
| 122 | MP0010768_mortality/aging | 0.61452482 |
| 123 | MP0001943_abnormal_respiration | 0.60844711 |
| 124 | MP0000049_abnormal_middle_ear | 0.58881171 |
| 125 | MP0010770_preweaning_lethality | 0.57397650 |
| 126 | MP0002082_postnatal_lethality | 0.57397650 |
| 127 | MP0003632_abnormal_nervous_system | 0.57326738 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.57192443 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.55988009 |
| 130 | MP0003634_abnormal_glial_cell | 0.54339251 |
| 131 | MP0000747_muscle_weakness | 0.52587277 |
| 132 | MP0003956_abnormal_body_size | 0.51729458 |
| 133 | MP0010769_abnormal_survival | 0.51359130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.11429326 |
| 2 | Myokymia (HP:0002411) | 6.31354315 |
| 3 | Febrile seizures (HP:0002373) | 5.62083923 |
| 4 | Focal seizures (HP:0007359) | 5.59983295 |
| 5 | Atonic seizures (HP:0010819) | 4.94160671 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.88318889 |
| 7 | Limb dystonia (HP:0002451) | 4.81365942 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.28776685 |
| 9 | Hyperventilation (HP:0002883) | 4.15663539 |
| 10 | Broad alveolar ridges (HP:0000187) | 4.14242383 |
| 11 | Absence seizures (HP:0002121) | 4.09304480 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.05412761 |
| 13 | Dialeptic seizures (HP:0011146) | 4.03619435 |
| 14 | Visual hallucinations (HP:0002367) | 3.93179556 |
| 15 | Drooling (HP:0002307) | 3.79118384 |
| 16 | Excessive salivation (HP:0003781) | 3.79118384 |
| 17 | Failure to thrive in infancy (HP:0001531) | 3.75597748 |
| 18 | Broad-based gait (HP:0002136) | 3.75104100 |
| 19 | Adactyly (HP:0009776) | 3.73703015 |
| 20 | Abnormal hair whorl (HP:0010721) | 3.52179915 |
| 21 | Neonatal respiratory distress (HP:0002643) | 3.48682249 |
| 22 | Pheochromocytoma (HP:0002666) | 3.40644336 |
| 23 | Polyphagia (HP:0002591) | 3.31222609 |
| 24 | Chronic hepatic failure (HP:0100626) | 3.13961551 |
| 25 | Poor suck (HP:0002033) | 3.12009467 |
| 26 | Neuroendocrine neoplasm (HP:0100634) | 3.07770976 |
| 27 | Fair hair (HP:0002286) | 3.07220123 |
| 28 | Spastic gait (HP:0002064) | 3.04297406 |
| 29 | Protruding tongue (HP:0010808) | 3.01531036 |
| 30 | Amyotrophic lateral sclerosis (HP:0007354) | 3.00954671 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.85140040 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.79087127 |
| 33 | Exotropia (HP:0000577) | 2.77102768 |
| 34 | Hypothermia (HP:0002045) | 2.75920422 |
| 35 | Abnormal social behavior (HP:0012433) | 2.70014900 |
| 36 | Impaired social interactions (HP:0000735) | 2.70014900 |
| 37 | Long foot (HP:0001833) | 2.69936174 |
| 38 | High anterior hairline (HP:0009890) | 2.68885852 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 2.68870421 |
| 40 | Generalized hypopigmentation of hair (HP:0011358) | 2.67598314 |
| 41 | Lissencephaly (HP:0001339) | 2.65855892 |
| 42 | Abnormality of the corticospinal tract (HP:0002492) | 2.65337258 |
| 43 | Spastic tetraplegia (HP:0002510) | 2.64235625 |
| 44 | Resting tremor (HP:0002322) | 2.63816735 |
| 45 | Esotropia (HP:0000565) | 2.61931216 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.61558202 |
| 47 | Mutism (HP:0002300) | 2.59994155 |
| 48 | Termporal pattern (HP:0011008) | 2.58735786 |
| 49 | Insidious onset (HP:0003587) | 2.58735786 |
| 50 | Pachygyria (HP:0001302) | 2.58195865 |
| 51 | Abnormality of salivation (HP:0100755) | 2.56649118 |
| 52 | Severe global developmental delay (HP:0011344) | 2.56647208 |
| 53 | Progressive inability to walk (HP:0002505) | 2.54794413 |
| 54 | Absent speech (HP:0001344) | 2.53985015 |
| 55 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.52637996 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.51336334 |
| 57 | Amblyopia (HP:0000646) | 2.50610539 |
| 58 | Blue irides (HP:0000635) | 2.49467555 |
| 59 | Torticollis (HP:0000473) | 2.49135263 |
| 60 | Sleep apnea (HP:0010535) | 2.47553018 |
| 61 | Truncal ataxia (HP:0002078) | 2.46446459 |
| 62 | Synostosis involving the elbow (HP:0003938) | 2.45104820 |
| 63 | Humeroradial synostosis (HP:0003041) | 2.45104820 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.45057249 |
| 65 | Depression (HP:0000716) | 2.41344471 |
| 66 | Akinesia (HP:0002304) | 2.40704364 |
| 67 | Hypoventilation (HP:0002791) | 2.38574676 |
| 68 | Renal hypoplasia (HP:0000089) | 2.36989200 |
| 69 | Hepatoblastoma (HP:0002884) | 2.36590700 |
| 70 | Growth hormone deficiency (HP:0000824) | 2.36202326 |
| 71 | Acute necrotizing encephalopathy (HP:0006965) | 2.35573366 |
| 72 | Anxiety (HP:0000739) | 2.34805854 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.33483577 |
| 74 | Narrow forehead (HP:0000341) | 2.31499387 |
| 75 | Oligomenorrhea (HP:0000876) | 2.31444964 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.30750240 |
| 77 | Delayed gross motor development (HP:0002194) | 2.29894840 |
| 78 | Focal dystonia (HP:0004373) | 2.28851793 |
| 79 | Abnormality of the labia minora (HP:0012880) | 2.28708016 |
| 80 | Hemiparesis (HP:0001269) | 2.26276610 |
| 81 | Status epilepticus (HP:0002133) | 2.24068991 |
| 82 | Craniofacial dystonia (HP:0012179) | 2.23179932 |
| 83 | Cortical dysplasia (HP:0002539) | 2.23104901 |
| 84 | True hermaphroditism (HP:0010459) | 2.20952746 |
| 85 | Specific learning disability (HP:0001328) | 2.20269867 |
| 86 | Hypoplasia of the brainstem (HP:0002365) | 2.18474384 |
| 87 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.18474384 |
| 88 | Sensory axonal neuropathy (HP:0003390) | 2.15212118 |
| 89 | Retinal dysplasia (HP:0007973) | 2.14460462 |
| 90 | Dysdiadochokinesis (HP:0002075) | 2.12930440 |
| 91 | Bradykinesia (HP:0002067) | 2.12682682 |
| 92 | Poor eye contact (HP:0000817) | 2.12471090 |
| 93 | Abnormality of binocular vision (HP:0011514) | 2.11933124 |
| 94 | Diplopia (HP:0000651) | 2.11933124 |
| 95 | Hyperthyroidism (HP:0000836) | 2.10595785 |
| 96 | Progressive macrocephaly (HP:0004481) | 2.09951735 |
| 97 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09685429 |
| 98 | Action tremor (HP:0002345) | 2.09129628 |
| 99 | Molar tooth sign on MRI (HP:0002419) | 2.09021429 |
| 100 | Abnormality of midbrain morphology (HP:0002418) | 2.09021429 |
| 101 | Urinary urgency (HP:0000012) | 2.08763670 |
| 102 | Agitation (HP:0000713) | 2.08435344 |
| 103 | Methylmalonic acidemia (HP:0002912) | 2.08187989 |
| 104 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06358543 |
| 105 | Hypoplastic pelvis (HP:0008839) | 2.05358762 |
| 106 | Increased hepatocellular lipid droplets (HP:0006565) | 2.05106587 |
| 107 | Neoplasm of the heart (HP:0100544) | 2.04609727 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04597376 |
| 109 | Clumsiness (HP:0002312) | 2.04346482 |
| 110 | Pancreatic cysts (HP:0001737) | 2.02223086 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 2.01972750 |
| 112 | Inability to walk (HP:0002540) | 2.00643367 |
| 113 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00528114 |
| 114 | Medulloblastoma (HP:0002885) | 2.00078304 |
| 115 | Generalized myoclonic seizures (HP:0002123) | 1.98871971 |
| 116 | Gait imbalance (HP:0002141) | 1.98472373 |
| 117 | Pancreatic fibrosis (HP:0100732) | 1.97989701 |
| 118 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.96655401 |
| 119 | Postural instability (HP:0002172) | 1.96403888 |
| 120 | Gait ataxia (HP:0002066) | 1.95982340 |
| 121 | Narrow nasal bridge (HP:0000446) | 1.95718684 |
| 122 | Dysmetria (HP:0001310) | 1.94989478 |
| 123 | Mitochondrial inheritance (HP:0001427) | 1.93380719 |
| 124 | Osteomalacia (HP:0002749) | 1.89401797 |
| 125 | Genetic anticipation (HP:0003743) | 1.87605017 |
| 126 | Abnormality of the alveolar ridges (HP:0006477) | 1.87134221 |
| 127 | Diminished movement (HP:0002374) | 1.86975904 |
| 128 | Incomplete penetrance (HP:0003829) | 1.85705427 |
| 129 | Papilledema (HP:0001085) | 1.84829170 |
| 130 | Shoulder girdle muscle weakness (HP:0003547) | 1.84498173 |
| 131 | Intellectual disability, mild (HP:0001256) | 1.84315027 |
| 132 | Psychosis (HP:0000709) | 1.82793320 |
| 133 | Dysmetric saccades (HP:0000641) | 1.80882509 |
| 134 | Inappropriate behavior (HP:0000719) | 1.79838307 |
| 135 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79459899 |
| 136 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79459899 |
| 137 | Aqueductal stenosis (HP:0002410) | 1.79144264 |
| 138 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78925056 |
| 139 | Ankle clonus (HP:0011448) | 1.78879719 |
| 140 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.78071808 |
| 141 | Increased muscle lipid content (HP:0009058) | 1.78044199 |
| 142 | Acute encephalopathy (HP:0006846) | 1.76722818 |
| 143 | Renal Fanconi syndrome (HP:0001994) | 1.76673776 |
| 144 | Spastic tetraparesis (HP:0001285) | 1.76613771 |
| 145 | Sclerocornea (HP:0000647) | 1.74474364 |
| 146 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.74253465 |
| 147 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.74253465 |
| 148 | Prominent supraorbital ridges (HP:0000336) | 1.70621250 |
| 149 | Abnormal number of incisors (HP:0011064) | 1.67727321 |
| 150 | Rhinitis (HP:0012384) | 1.66754043 |
| 151 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.66569847 |
| 152 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.66569847 |
| 153 | Abnormal EKG (HP:0003115) | 1.66335701 |
| 154 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.65372930 |
| 155 | Split foot (HP:0001839) | 1.65229871 |
| 156 | Medial flaring of the eyebrow (HP:0010747) | 1.63112330 |
| 157 | Pelvic girdle muscle weakness (HP:0003749) | 1.62753136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 5.54652410 |
| 2 | CASK | 4.87047336 |
| 3 | PRKD3 | 4.34699945 |
| 4 | MAP3K4 | 3.86307052 |
| 5 | MAP2K7 | 3.57641038 |
| 6 | NTRK3 | 3.35397789 |
| 7 | MAP3K12 | 2.98527156 |
| 8 | MINK1 | 2.87319582 |
| 9 | SIK2 | 2.76979909 |
| 10 | CLK1 | 2.72302505 |
| 11 | MARK1 | 2.69935003 |
| 12 | MAP2K4 | 2.50661913 |
| 13 | BCR | 2.43693940 |
| 14 | TSSK6 | 2.21537174 |
| 15 | FRK | 2.21259690 |
| 16 | FGFR3 | 2.11839776 |
| 17 | NTRK2 | 1.87744590 |
| 18 | PLK2 | 1.81023451 |
| 19 | GRK5 | 1.78161928 |
| 20 | EPHA4 | 1.72457082 |
| 21 | MAP3K9 | 1.67087737 |
| 22 | CDK19 | 1.61127034 |
| 23 | KSR1 | 1.59281677 |
| 24 | PINK1 | 1.58584045 |
| 25 | MAPK13 | 1.58297181 |
| 26 | PNCK | 1.57849187 |
| 27 | SRPK1 | 1.52115018 |
| 28 | PAK6 | 1.51284592 |
| 29 | RIPK4 | 1.49057232 |
| 30 | MAP4K2 | 1.34914254 |
| 31 | UHMK1 | 1.32837171 |
| 32 | CAMK2A | 1.29806202 |
| 33 | TNIK | 1.24267672 |
| 34 | CDK5 | 1.22895799 |
| 35 | PRKCG | 1.18669613 |
| 36 | NME1 | 1.09708994 |
| 37 | MAPK4 | 1.04724614 |
| 38 | OXSR1 | 1.03778319 |
| 39 | NTRK1 | 0.99665507 |
| 40 | CAMK4 | 0.99649760 |
| 41 | CAMK2B | 0.96589315 |
| 42 | PTK2B | 0.96512537 |
| 43 | CCNB1 | 0.94400377 |
| 44 | CSNK1G2 | 0.94373614 |
| 45 | AKT3 | 0.92709976 |
| 46 | FES | 0.91937889 |
| 47 | IRAK2 | 0.91629620 |
| 48 | TAF1 | 0.91199966 |
| 49 | LATS2 | 0.90618736 |
| 50 | FGR | 0.90242571 |
| 51 | MAPK15 | 0.88232769 |
| 52 | DAPK1 | 0.86933802 |
| 53 | BMPR1B | 0.85690834 |
| 54 | CDK18 | 0.85077484 |
| 55 | PHKG1 | 0.84543119 |
| 56 | PHKG2 | 0.84543119 |
| 57 | SGK2 | 0.76443973 |
| 58 | CSNK1G3 | 0.75650287 |
| 59 | TAOK1 | 0.74546698 |
| 60 | WNK3 | 0.73083626 |
| 61 | RET | 0.72966133 |
| 62 | SGK494 | 0.72509719 |
| 63 | SGK223 | 0.72509719 |
| 64 | MAPKAPK5 | 0.72123748 |
| 65 | BMPR2 | 0.71725515 |
| 66 | PASK | 0.71667618 |
| 67 | DAPK2 | 0.71615447 |
| 68 | MAP3K6 | 0.68780616 |
| 69 | BCKDK | 0.68556248 |
| 70 | PRKCE | 0.68418543 |
| 71 | CAMK2D | 0.67678562 |
| 72 | PRPF4B | 0.67656105 |
| 73 | TIE1 | 0.67557261 |
| 74 | CDK14 | 0.65533465 |
| 75 | CDK8 | 0.65195300 |
| 76 | CAMK2G | 0.63522200 |
| 77 | ERBB4 | 0.62605548 |
| 78 | CDK15 | 0.62396983 |
| 79 | CDK3 | 0.61893508 |
| 80 | MYLK | 0.60185010 |
| 81 | CSNK1A1L | 0.60158343 |
| 82 | ARAF | 0.57361086 |
| 83 | DYRK1A | 0.56666848 |
| 84 | MAPK9 | 0.54073873 |
| 85 | PKN1 | 0.54071580 |
| 86 | DYRK2 | 0.53799262 |
| 87 | FER | 0.53723391 |
| 88 | LIMK1 | 0.52005324 |
| 89 | RPS6KA2 | 0.51858805 |
| 90 | GRK6 | 0.50830202 |
| 91 | CDK11A | 0.49333217 |
| 92 | ADRBK1 | 0.48838187 |
| 93 | MAP3K7 | 0.46683951 |
| 94 | DYRK3 | 0.45023645 |
| 95 | EPHB2 | 0.44828275 |
| 96 | ERBB3 | 0.44225756 |
| 97 | PAK3 | 0.43124213 |
| 98 | FYN | 0.43123227 |
| 99 | SGK1 | 0.41664030 |
| 100 | TGFBR1 | 0.41140510 |
| 101 | ADRBK2 | 0.40397417 |
| 102 | MARK2 | 0.40387896 |
| 103 | GRK7 | 0.40305666 |
| 104 | VRK1 | 0.38628648 |
| 105 | CSNK1G1 | 0.37902197 |
| 106 | PRKACB | 0.37831304 |
| 107 | INSRR | 0.37481132 |
| 108 | MKNK2 | 0.36819324 |
| 109 | STK16 | 0.36683119 |
| 110 | PRKACA | 0.36473991 |
| 111 | TAOK3 | 0.36440377 |
| 112 | ERBB2 | 0.36389013 |
| 113 | CAMK1 | 0.35906879 |
| 114 | CSNK1A1 | 0.35792751 |
| 115 | PRKCH | 0.35539523 |
| 116 | PRKCB | 0.35444128 |
| 117 | RPS6KA3 | 0.35343121 |
| 118 | PAK1 | 0.35318385 |
| 119 | TGFBR2 | 0.34680255 |
| 120 | SGK3 | 0.32744365 |
| 121 | CAMKK2 | 0.31859998 |
| 122 | SIK1 | 0.31769275 |
| 123 | PRKACG | 0.31653056 |
| 124 | PRKCA | 0.31641797 |
| 125 | GSK3B | 0.31576893 |
| 126 | CSNK1E | 0.31338002 |
| 127 | PRKCZ | 0.29529857 |
| 128 | PRKG1 | 0.28961117 |
| 129 | STK11 | 0.27177838 |
| 130 | CAMKK1 | 0.27009984 |
| 131 | CDC42BPA | 0.26482769 |
| 132 | SRC | 0.26274681 |
| 133 | MAPK7 | 0.26242490 |
| 134 | IRAK1 | 0.25905550 |
| 135 | MAPK12 | 0.25781486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.66838121 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.92645667 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.18210761 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.05574057 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.81087866 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60806727 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.48389877 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.37459358 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.31020689 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.30842646 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28745516 |
| 12 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.24793775 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.24498104 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.24250889 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.20031898 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.11217696 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 2.08672561 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07043525 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.93574160 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.85755972 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79843357 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.75816802 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.73653074 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.70859087 |
| 25 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.67612939 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.66898567 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66252939 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.61924226 |
| 29 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.58739551 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.58474410 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.50806182 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48895358 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44819709 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.41372183 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40371927 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39480278 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.28871232 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27487065 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27013399 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26869872 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24774437 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22566967 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22104049 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.17310422 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16024655 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15876115 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.13084886 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13019487 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11792703 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08318923 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07415175 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02519144 |
| 53 | Phototransduction_Homo sapiens_hsa04744 | 0.94704965 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94055067 |
| 55 | Protein export_Homo sapiens_hsa03060 | 0.91590232 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90266452 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84722665 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84250258 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83590460 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.83410301 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82076237 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81811214 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81705521 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79778282 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79430922 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76458860 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.72601200 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71591315 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70840915 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.70684516 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70017271 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69847452 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67933175 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67372137 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65960338 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62978743 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62830220 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62563698 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62236601 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61637336 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61431890 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61065918 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56780810 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54725227 |
| 85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54525342 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52257323 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51438823 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51406434 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48188929 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.48116803 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46680601 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42974956 |
| 93 | Proteasome_Homo sapiens_hsa03050 | 0.42598859 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41591673 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.41011038 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40942427 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40892146 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.40006135 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39150807 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38908449 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37944590 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37928766 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34861950 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34653421 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34605736 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34119098 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32954921 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32346042 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32097862 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31879852 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31490676 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.31278252 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31147556 |
| 114 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31059936 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31044907 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30544772 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29089265 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28935189 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27430492 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26894225 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.25976879 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25721864 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23942446 |
| 124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23936545 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23760867 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23568212 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.22900053 |
| 128 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.22458796 |
| 129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.21944265 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21915982 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21651880 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20935218 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19953186 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19735702 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.17679304 |

